Ƶ

Professor Maria Kavallaris

Professor Maria Kavallaris

Conjoint Professor

PhD - University of New South Wales

B App Sci - University of Technology Sydney

Medicine & Health
School of Clinical Medicine

Professor Maria Kavallaris AM is Founding Director of the Australian Centre for NanoMedicine at the University of New South Wales, Head of the Translational Cancer Nanomedicine Theme at the Children’s Cancer Institute and a National Health and Medical Research Council (NHMRC) Investigator. Maria is recognised for her innovation in driving multidisciplinary research in cancer nanomedicine. An outstanding scientific leader, she is internationally recognised for her research in cancer biology and therapeutics. Her research has identified clinically important mechanisms of resistance to cancer therapies, with her discoveries leading to patents, industry and clinical linkages for the development of cancer therapeutics and devices. Maria’s pioneering research has shown effective nanoparticle-based delivery of gene silencing material and chemotherapy, can reduce tumour growth in aggressive cancers.

Maria is Chair of the Australian Institute for Policy and Science, and a Life Member and past-President of the Australian Society for Medical Research. The impact of her research has been recognised many times, including via receipt of the Australian Museum Eureka Prize, as well as being named by the NHMRC as an Australian ‘high achiever’ in health and medical research. Recognition of her significant contributions to innovation is reflected in her being named in 2015 amongst the AFR/Westpac 100 Women of Influence (Innovation category), as well as the inaugural Knowledge Nation 100 – the ‘rock stars’ of Australia's innovation-driven new economy, and she received the 2017 Premiers Science and Engineering Award for Leadership in Innovation in NSW. In 2019, she was awarded the Lemberg Medal, a prestigious award bestowed by ASBMB; and has won both the 2019 UTS Chancellor’s Excellence Award and the 2019 UTS Alumni Excellence Award for Science. She is an elected Fellow of both the Australian Academy of Health and Medical Sciences and the Royal Society of New South Wales. Maria was named the 2020 NSW Premier's Woman of the Year.

A recognised medical research leader, she has been appointed on government funding panels including NHMRC Research Committee, NHMRC Women in Health Sciences Committee, and the Medical Research Future Fund Stem Cell Therapies Advisory Committee, where she contributes to high level policy. In 2019, Maria was appointed a Member (AM) of the Order of Australia for her significant service to medicine, and to medical research, in the field of childhood and adult cancers. Maria received the 2022 Presidential Medal for Outstanding Contributions, Republic of Cyprus.

Phone
93852028
Location
Children's Cancer Institute Lowy Cancer Research Centre Building C25
  • Books | 2012
    Kavallaris M, 2012, Cytoskeleton and human disease,
    Books | 2011
    Kavallaris M, 2011, Preface,
  • Book Chapters | 2019
    McCarroll JA; Sharbeen G; Kavallaris M; Phillips PA, 2019, 'The use of star polymer nanoparticles for the delivery of siRNA to mouse orthotopic pancreatic tumor models', in RNA interference and cancer therapy : methods and protocols, pp. 329 - 353,
    Book Chapters | 2017
    Mansfeld FM; Davis TP; Kavallaris M, 2017, 'Chapter Two Nanotechnology in Medical Research', in Micro and Nanotechnology in Vaccine Development, Elsevier, pp. 21 - 45,
    Book Chapters | 2017
    Mansfeld FM; Davis TP; Kavallaris M, 2017, 'Nanotechnology in Medical Research', in Skwarczynski M; Toth I (ed.), Micro- and Nanotechnology in Vaccine Development, William Andrew Elsevier, Oxford, UK, pp. 21 - 45,
    Book Chapters | 2014
    Kavallaris M; Pasquier E; Andre N, 2014, 'Metronomic Chemotherapy regimens using microtubule-targeting agents:mechanisms of action, pre-clinical activity and future developments.', in Bocci G; Francia G (ed.), Metronomic Chemotherapy, Springer, pp. 69 - 90,
    Book Chapters | 2013
    Erlich RB; Kavallaris M; McCarroll J; Phillips P, 2013, 'Nanotechnology, tumour biomarkers and RNA interference for personalized medicine applications', in Shiddiky MJA; Wee EJH; Rauf S; Trau M (ed.), Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications, Nova Science Publishers, pp. 167 - 187,
    Book Chapters | 2013
    Vittorio O; Kavallaris , 2013, 'Polyphenol Conjugate: Synthesis and Potential Biomedical Applications', in Recent Advances in Drug Delivery Research, Nova Science Publishers, USA
    Book Chapters | 2012
    McCarroll JA; Kavallaris M, 2012, 'Microtubules, drug resistance, and tumorigenesis', in Cytoskeleton and Human Disease, pp. 223 - 240,
    Book Chapters | 2000
    Haber M; Kavallaris M, 2000, 'Multidrug Resistance Genes in Neuroblastoma', in Neuroblastoma, Elsevier Science BV, Amsterdam, pp. 207 - 215
    Book Chapters |
    Kavallaris M; Don S; Verrills NM, 'Microtubule-Associated Proteins and Microtubule-Interacting Proteins', in The Role of Microtubules in Cell Biology, Neurobiology, and Oncology, Humana Press, pp. 83 - 104,
  • Journal articles | 2024
    Evans L; Walker R; MacDiarmid J; Brahmbhatt H; Anazodo A; McCowage G; Gifford AJ; Kavallaris M; Trahair T; Ziegler DS, 2024, 'A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor', Targeted Oncology, 19, pp. 333 - 342,
    Journal articles | 2024
    Forgham H; Zhu J; Huang X; Zhang C; Biggs H; Liu L; Wang YC; Fletcher N; Humphries J; Cowin G; Mardon K; Kavallaris M; Thurecht K; Davis TP; Qiao R, 2024, 'Multifunctional Fluoropolymer-Engineered Magnetic Nanoparticles to Facilitate Blood-Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma', Advanced Science, 11,
    Journal articles | 2024
    Graber P; Dolman MEM; Jung MS; Kavallaris M, 2024, 'Ex Vivo Modeling of the Tumor Microenvironment to Develop Therapeutic Strategies for Gliomas', Advanced Therapeutics,
    Journal articles | 2024
    Hassan N; Yi H; Malik B; Gaspard-Boulinc L; Samaraweera SE; Casolari DA; Seneviratne J; Balachandran A; Chew T; Duly A; Carter DR; Cheung BB; Norris M; Haber M; Kavallaris M; Marshall GM; Zhang XD; Liu T; Wang J; Liebermann DA; D'Andrea RJ; Wang JY, 2024, 'Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML', Blood, 144, pp. 84 - 98,
    Journal articles | 2024
    Holliday H; Yang J; Dodson E; Nikolic I; Kamili A; Wheatley M; Deng N; Alexandrou S; Davis TP; Kavallaris M; Caldon CE; McCarroll J; De Preter K; Mestdagh P; Marshall GM; Simpson KJ; Fletcher J; Swarbrick A, 2024, 'Erratum: miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma (Molecular Therapy (2022) 30(3) (1119–1134), (S1525001622000041), (10.1016/j.ymthe.2022.01.004))', Molecular Therapy, 32, pp. 2031 - 2033,
    Journal articles | 2024
    Joyce P; Allen CJ; Alonso MJ; Ashford M; Bradbury MS; Germain M; Kavallaris M; Langer R; Lammers T; Peracchia MT; Popat A; Prestidge CA; Rijcken CJF; Sarmento B; Schmid RB; Schroeder A; Subramaniam S; Thorn CR; Whitehead KA; Zhao CX; Santos HA, 2024, 'A translational framework to DELIVER nanomedicines to the clinic', Nature Nanotechnology,
    Journal articles | 2024
    Logan A; Howard CB; Huda P; Kimpton K; Ma Z; Thurecht KJ; McCarroll JA; Moles E; Kavallaris M, 2024, 'Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.', Journal of Controlled Release, 367, pp. 806 - 820,
    Journal articles | 2024
    Mohamed SMA; Schofield P; McCalmont H; Moles E; Friedrich KH; Kavallaris M; Christ D; Bayat N; Lock RB, 2024, 'An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 254, pp. 127596,
    Journal articles | 2024
    Moles E; Chang DW; Mansfeld FM; Duly A; Kimpton K; Logan A; Howard CB; Thurecht KJ; Kavallaris M, 2024, 'EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer', International Journal of Nanomedicine, 19, pp. 3623 - 3639,
    Journal articles | 2024
    Poltavets V; Jung M; Skhinas J; Kimpton K; Kamili A; Tax G; Mao J; Cui L; Wong M; Cowley MJ; Lau L; Dolman EME; Gooding JJ; Kavallaris M, 2024, 'Abstract 5475: Development of high-throughput 3D bioprinted pediatric models for precision medicine', Cancer Research, 84, pp. 5475 - 5475,
    Journal articles | 2023
    Brayford S; Duly A; Teo WS; Dwarte T; Gonzales-Aloy E; Ma Z; McVeigh L; Failes TW; Arndt GM; McCarroll JA; Kavallaris M, 2023, 'βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cells', Cancer Medicine, 12, pp. 4455 - 4471,
    Journal articles | 2023
    Du EY; Jung MS; Skhinas J; Tolentino MAK; Noy J; Jamshidi N; Houng JL; Tjandra KC; Engel M; Utama R; Tilley RD; Kavallaris M; Gooding JJ, 2023, '3D Bioprintable Hydrogel with Tunable Stiffness for Exploring Cells Encapsulated in Matrices of Differing Stiffnesses', ACS Applied Bio Materials, 6, pp. 4603 - 4612,
    Journal articles | 2023
    Gonzales-Aloy E; Ahmed-Cox A; Tsoli M; Ziegler DS; Kavallaris M, 2023, 'From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer', Advanced Drug Delivery Reviews, 196,
    Journal articles | 2023
    Janjua TI; Cao Y; Ahmed-Cox A; Raza A; Moniruzzaman M; Akhter DT; Fletcher NL; Kavallaris M; Thurecht KJ; Popat A, 2023, 'Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma', Journal of Controlled Release, 357, pp. 161 - 174,
    Journal articles | 2023
    Moles E; Howard CB; Huda P; Karsa M; McCalmont H; Kimpton K; Duly A; Chen Y; Huang Y; Tursky ML; Ma D; Bustamante S; Pickford R; Connerty P; Omari S; Jolly CJ; Joshi S; Shen S; Pimanda JE; Dolnikov A; Cheung LC; Kotecha RS; Norris MD; Haber M; de Bock CE; Somers K; Lock RB; Thurecht KJ; Kavallaris M; Moles Meler E, 2023, 'Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia', Science translational medicine, 15, pp. eabm1262 - eabm1262,
    Journal articles | 2023
    Nguyen DHT; Utama RH; Tjandra KC; Suwannakot P; Du EY; Kavallaris M; Tilley RD; Gooding JJ, 2023, 'Tuning the Mechanical Properties of Multiarm RAFT-Based Block Copolyelectrolyte Hydrogels via Ionic Cross-Linking for 3D Cell Cultures', Biomacromolecules, 24, pp. 57 - 68,
    Journal articles | 2023
    Suwannakot P; Nemec S; Peres NG; Du EY; Kilian KA; Gaus K; Kavallaris M; Gooding JJ, 2023, 'Electrostatic Assembly of Multiarm PEG-Based Hydrogels as Extracellular Matrix Mimics: Cell Response in the Presence and Absence of RGD Cell Adhesive Ligands', ACS Biomaterials Science and Engineering, 9, pp. 1362 - 1376,
    Journal articles | 2022
    Ahmed-Cox A; Macmillan AM; Pandzic E; Whan RM; Kavallaris M, 2022, 'Application of Rapid Fluorescence Lifetime Imaging Microscopy (RapidFLIM) to Examine Dynamics of Nanoparticle Uptake in Live Cells', Cells, 11,
    Journal articles | 2022
    Ahmed-Cox A; Pandzic E; Johnston ST; Heu C; McGhee J; Mansfeld FM; Crampin EJ; Davis TP; Whan RM; Kavallaris M, 2022, 'Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density', Journal of Controlled Release, 341, pp. 661 - 675,
    Journal articles | 2022
    Cong VT; Houng JL; Kavallaris M; Chen X; Tilley RD; Gooding JJ, 2022, 'How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?', Chemical Society Reviews, 51, pp. 7531 - 7559,
    Journal articles | 2022
    Duly AMP; Kao FCL; Teo WS; Kavallaris M, 2022, 'βIII-Tubulin Gene Regulation in Health and Disease', Frontiers in Cell and Developmental Biology, 10,
    Journal articles | 2022
    Holliday H; Yang J; Dodson E; Nikolic I; Kamili A; Wheatley M; Deng N; Alexandrou S; Davis TP; Kavallaris M; Caldon CE; McCarroll J; De Preter K; Mestdagh P; Marshall GM; Simpson KJ; Fletcher J; Swarbrick A, 2022, 'miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma', Molecular Therapy, 30, pp. 1119 - 1134,
    Journal articles | 2022
    Jung MS; Ghamrawi S; Du EY; Gooding JJ; Kavallaris M, 2022, 'Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application', Advanced Healthcare Materials, 11, pp. e2200690,
    Journal articles | 2022
    Jung MS; Skhinas JN; Du EY; Tolentino MAK; Utama RH; Engel M; Volkerling A; Sexton A; O'Mahony AP; Ribeiro JCC; Gooding JJ; Kavallaris M, 2022, 'A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability', Biomaterials Science, 10, pp. 5876 - 5887,
    Journal articles | 2022
    Karsa M; Ronca E; Bongers A; Mariana A; Moles E; Failes TW; Arndt GM; Cheung LC; Kotecha RS; Kavallaris M; Haber M; Norris MD; Henderson MJ; Xiao L; Somers K; Moles Meler E, 2022, 'Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia', Frontiers in Oncology, 11, pp. 779859,
    Journal articles | 2022
    Ma Z; Wong SW; Forgham H; Esser L; Lai M; Leiske MN; Kempe K; Sharbeen G; Youkhana J; Mansfeld F; Quinn JF; Phillips PA; Davis TP; Kavallaris M; McCarroll JA, 2022, 'Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth', Biomaterials, 285,
    Journal articles | 2022
    Muskovic W; Slavich E; Maslen B; Kaczorowski DC; Cursons J; Crampin E; Kavallaris M, 2022, 'High temporal resolution RNA-seq time course data reveals widespread synchronous activation between mammalian lncRNAs and neighboring protein-coding genes', Genome Research, 32, pp. 1463 - 1473,
    Journal articles | 2022
    Parker AL; Teo WS; Brayford S; Moorthi UK; Arumugam S; Ferguson C; Parton RG; McCarroll JA; Kavallaris M, 2022, 'βIII-Tubulin Structural Domains Regulate Mitochondrial Network Architecture in an Isotype-Specific Manner', Cells, 11,
    Journal articles | 2022
    Sumer-Bayraktar Z; Fife CM; Byrne FL; Kavallaris M; Packer NH, 2022, 'Membrane glycome is impacted by the cell culturing mode of neuroblastoma cells with differing migration and invasion potential', Glycobiology, 32, pp. 588 - 599,
    Journal articles | 2022
    Upton DH; Ung C; George SM; Tsoli M; Kavallaris M; Ziegler DS, 2022, 'Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy', Theranostics, 12, pp. 4734 - 4752,
    Journal articles | 2021
    Connerty P; Moles E; de Bock CE; Jayatilleke N; Smith JL; Meshinchi S; Mayoh C; Kavallaris M; Lock RB; Moles Meler E, 2021, 'Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for t(8;21) pediatric acute myeloid leukemia', Pharmaceutics, 13, pp. 1681,
    Journal articles | 2021
    Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C, 2021, 'Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells', Nanoscale, 13, pp. 11414 - 11426,
    Journal articles | 2021
    Grohmann C; Walker F; Devlin M; Luo MX; Chüeh AC; Doherty J; Vaillant F; Ho GY; Wakefield MJ; Weeden CE; Kamili A; Murray J; Po’uha ST; Weinstock J; Kane SR; Faux MC; Broekhuizen E; Zheng Y; Shield-Artin K; Kershaw NJ; Tan CW; Witchard HM; Ebert G; Charman SA; Street I; Kavallaris M; Haber M; Fletcher JI; Asselin-Labat ML; Scott CL; Visvader JE; Lindeman GJ; Watson KG; Burgess AW; Lessene G, 2021, 'Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors', Cell Death and Disease, 12, pp. 268,
    Journal articles | 2021
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A, 2021, 'Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma', Nanoscale, 13, pp. 16909 - 16922,
    Journal articles | 2021
    Janjua TI; Rewatkar P; Ahmed-Cox A; Saeed I; Mansfeld FM; Kulshreshtha R; Kumeria T; Ziegler DS; Kavallaris M; Mazzieri R; Popat A, 2021, 'Frontiers in the treatment of glioblastoma: Past, present and emerging', Advanced Drug Delivery Reviews, 171, pp. 108 - 138,
    Journal articles | 2021
    Mohamed SMA; Wohlmann A; Schofield P; Sia KCS; McCalmont H; Savvides SN; Verstraete K; Kavallaris M; Christ D; Friedrich KH; Bayat N; Lock RB, 2021, 'A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 190, pp. 214 - 223,
    Journal articles | 2021
    Muskovic W; Slavich E; Maslen B; Kaczorowski D; Cursons J; Crampin E; Kavallaris M, 2021, 'High temporal resolution RNA-seq time course data reveals mammalian lncRNA activation mirrors neighbouring protein-coding genes', ,
    Journal articles | 2021
    Putra V; Hulme AJ; Tee AE; Sun JQJ; Atmadibrata B; Ho N; Chen J; Gao J; Norris MD; Haber M; Kavallaris M; Henderson MJ; McCarroll J; Trahair T; Liu T; Liu PY, 2021, 'The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma', Molecular Oncology, 15, pp. 1162 - 1179,
    Journal articles | 2021
    Ung C; Tsoli M; Liu J; Cassano D; Pocoví-Martínez S; Upton DH; Ehteda A; Mansfeld FM; Failes TW; Farfalla A; Katsinas C; Kavallaris M; Arndt GM; Vittorio O; Cirillo G; Voliani V; Ziegler DS, 2021, 'Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma', Cancers, 13, pp. 1 - 20,
    Journal articles | 2021
    Utama RH; Tan VTG; Tjandra KC; Sexton A; Nguyen DHT; O'Mahony AP; Du EY; Tian P; Ribeiro JCC; Kavallaris M; Gooding JJ, 2021, 'A Covalently Crosslinked Ink for Multimaterials Drop-on-Demand 3D Bioprinting of 3D Cell Cultures', Macromolecular Bioscience, 21, pp. e2100125,
    Journal articles | 2021
    Utama RH; Tan VTG; Tjandra KC; Sexton A; Nguyen DHT; O’Mahony AP; Ribeiro JCC; Kavallaris M; Gooding JJ, 2021, 'A covalently crosslinked bioink for multi-materials drop-on-demand 3D bioprinting of three-dimensional cell cultures', , pp. 2021.02.18.431759,
    Journal articles | 2021
    Yang Y; Mansfeld FM; Kavallaris M; Gaus K; Tilley RD; Gooding JJ, 2021, 'Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noise', Chemical Science, 12, pp. 2558 - 2566,
    Journal articles | 2021
    Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Hung T; Power C; Hardy P; D D; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE; Chacon Fajardo D, 2021, 'Induction of Muscle Regenerative Multipotent Stem Cells from Human Adipocytes by PDGF-AB and 5-Azacytidine', Science Advances, pp. 2020.06.04.130872 - 2020.06.04.130872,
    Journal articles | 2021
    Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Srivastava P; Potas JR; Hung T; Power C; Hardy P; Ma DD; Kilian KA; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE; Subramanian S, 2021, 'Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine', Science Advances, 7, pp. eabd1929,
    Journal articles | 2020
    Keenan B; Finol-Urdaneta RK; Hope A; Bremner JB; Kavallaris M; Lucena-Agell D; Oliva MA; Diaz JF; Vine KL, 2020, 'N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity', CANCER CELL INTERNATIONAL, 20,
    Journal articles | 2020
    Le Grand M; Kimpton K; Gana CC; Valli E; Fletcher JI; Kavallaris M, 2020, 'Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma', ACS Pharmacology and Translational Science, 3, pp. 148 - 160,
    Journal articles | 2020
    Po’uha ST; Le Grand M; Brandl MB; Gifford AJ; Goodall GJ; Khew-Goodall Y; Kavallaris M, 2020, 'Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration', British Journal of Cancer, 122, pp. 434 - 444,
    Journal articles | 2020
    Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY, 2020, 'Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia', Cancer Cell, 38, pp. 263 - 278.e6,
    Journal articles | 2020
    Tjandra KC; Forest CR; Wong CK; Alcantara S; Kelly HG; Ju Y; Stenzel MH; McCarroll JA; Kavallaris M; Caruso F; Kent SJ; Thordarson P, 2020, 'Modulating the Selectivity and Stealth Properties of Ellipsoidal Polymersomes through a Multivalent Peptide Ligand Display', Advanced Healthcare Materials, 9,
    Journal articles | 2020
    Tjandra KC; McCarthy N; Yang L; Laos AJ; Sharbeen G; Phillips PA; Forgham H; Sagnella SM; Whan RM; Kavallaris M; Thordarson P; McCarroll JA, 2020, 'Identification of Novel Medulloblastoma Cell-Targeting Peptides for Use in Selective Chemotherapy Drug Delivery', Journal of Medicinal Chemistry, 63, pp. 2181 - 2193,
    Journal articles | 2020
    Utama RH; Atapattu L; O'Mahony AP; Fife CM; Baek J; Allard T; O'Mahony KJ; Ribeiro JCC; Gaus K; Kavallaris M; Gooding JJ, 2020, 'A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids', iScience, 23, pp. 101621,
    Journal articles | 2020
    Utama RH; Atapattu L; O’Mahony AP; Fife CM; Baek J; Allard T; O’Mahony KJ; Ribeiro J; Gaus K; Kavallaris M; Gooding JJ, 2020, 'Precise, high-throughput production of multicellular spheroids with a bespoke 3D bioprinter', , pp. 2020.04.06.028548,
    Journal articles | 2020
    Vittorio O; Kamili A; Valli E; Kavallaris M; LE GRAND M, 2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics, 10, pp. 6411 - 6429,
    Journal articles | 2020
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2020, 'Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion', Cancer Research, 80, pp. 4129 - 4144,
    Journal articles | 2019
    Bayat N; McOrist N; Ariotti N; Lai M; Sia KCS; Li Y; Grace JL; Quinn JF; Whittaker MR; Kavallaris M; Davis TP; Lock RB, 2019, 'Thiol-reactive star polymers functionalized with short ethoxy-containing moieties exhibit enhanced uptake in acute lymphoblastic leukemia cells', International Journal of Nanomedicine, 14, pp. 9795 - 9808,
    Journal articles | 2019
    Cirillo G; Peitzsch C; Vittorio O; Curcio M; Farfalla A; Voli F; Dubrovska A; Iemma F; Kavallaris M; Hampel S, 2019, 'When polymers meet carbon nanostructures: Expanding horizons in cancer therapy', Future Medicinal Chemistry, 11, pp. 2205 - 2231,
    Journal articles | 2019
    Moles E; Kavallaris M; Fernàndez-Busquets X, 2019, 'Modeling the distribution of diprotic basic drugs in liposomal systems: Perspectives on malaria nanotherapy', Frontiers in Pharmacology, 10,
    Journal articles | 2019
    Moles E; Kavallaris M, 2019, 'A potent targeted cancer nanotherapeutic', Nature Biomedical Engineering, 3, pp. 248 - 250,
    Journal articles | 2019
    Somers K; Wen VW; Middlemiss SMC; Osborne B; Forgham H; Jung MS; Karsa M; Clifton M; Bongers A; Gao J; Mayoh C; Raoufi-Rad N; Kusnadi EP; Hannan KM; Scott DA; Kwek A; Liu B; Flemming C; Chudakova DA; Pandher R; Failes TW; Lim J; Angeli A; Osterman AL; Imamura T; Kees UR; Supuran CT; Pearson RB; Hannan RD; Davis TP; McCarroll J; Kavallaris M; Turner N; Gudkov AV; Haber M; Norris MD; Henderson MJ, 2019, 'A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction', Oncogene, 38, pp. 3824 - 3842,
    Journal articles | 2019
    Xie W; Guo Z; Cao Z; Gao Q; Wang D; Boyer C; Kavallaris M; Sun X; Wang X; Zhao L; Gu Z, 2019, 'Manganese-Based Magnetic Layered Double Hydroxide Nanoparticle: A pH-Sensitive and Concurrently Enhanced T1/ T2-Weighted Dual-Mode Magnetic Resonance Imaging Contrast Agent', ACS Biomaterials Science and Engineering, 5, pp. 2555 - 2562,
    Journal articles | 2018
    Chang D; Lim M; Goos JACM; Qiao R; Ng YY; Mansfeld FM; Jackson M; Davis TP; Kavallaris M, 2018, 'Biologically targeted magnetic hyperthermia: Potential and limitations', Frontiers in Pharmacology, 9, pp. 831,
    Journal articles | 2018
    Faria M; Björnmalm M; Thurecht KJ; Kent SJ; Parton RG; Kavallaris M; Johnston APR; Gooding JJ; Corrie SR; Boyd BJ; Thordarson P; Whittaker AK; Stevens MM; Prestidge CA; Porter CJH; Parak WJ; Davis TP; Crampin EJ; Caruso F, 2018, 'Minimum information reporting in bio–nano experimental literature', Nature Nanotechnology, 13, pp. 777 - 785,
    Journal articles | 2018
    Levrier C; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Sadowski MC; Nelson CC, 2018, 'Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells', Cell Cycle, 17, pp. 652 - 668,
    Journal articles | 2018
    Oliver S; Yee E; Kavallaris M; Vittorio O; Boyer C, 2018, 'Water Soluble Antioxidant Dextran–Quercetin Conjugate with Potential Anticancer Properties', Macromolecular Bioscience, 18,
    Journal articles | 2018
    Parker AL; Teo WS; Pandzic E; Vicente JJ; McCarroll JA; Wordeman L; Kavallaris M, 2018, 'β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells', Life Science Alliance, 1,
    Journal articles | 2018
    Parker SG; Yang Y; Ciampi S; Gupta B; Kimpton K; Mansfeld FM; Kavallaris M; Gaus K; Justin Gooding J; Gooding J, 2018, 'A photoelectrochemical platform for the capture and release of rare single cells', Nature Communications, 9, pp. 2288,
    Journal articles | 2018
    Parmar A; Pascali G; Voli F; Lerra L; Yee E; Ahmed-Cox A; Kimpton K; Cirillo G; Arthur A; Zahra D; Rahardjo G; Liu GJ; Lengkeek N; Saletta F; Charil A; Kavallaris M; Vittorio O, 2018, 'In vivo [64Cu]CuCl2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis', Theranostics, 8, pp. 5645 - 5659,
    Journal articles | 2018
    Sagnella SM; Trieu J; Brahmbhatt H; MacDiarmid JA; MacMillan A; Whan RM; Fife CM; McCarroll JA; Gifford AJ; Ziegler DS; Kavallaris M, 2018, 'Targeted doxorubicin-loaded bacterially derived nano-cells for the treatment of neuroblastoma', Molecular Cancer Therapeutics, 17, pp. 1012 - 1023,
    Journal articles | 2018
    Tavallaie R; McCarroll J; Le Grand M; Ariotti N; Schuhmann W; Bakker E; Tilley RD; Hibbert DB; Kavallaris M; Gooding JJ; Hibbert B, 2018, 'Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood', Nature Nanotechnology, 13, pp. 1066 - 1071,
    Journal articles | 2018
    Voli F; Lerra L; Kimpton K; Saletta F; Cirillo G; Kavallaris M; Vittorio O, 2018, 'Harnessing copper in cancer to enhance anti-tumor immune response', Annals of Oncology, 29, pp. x35 - x35,
    Journal articles | 2017
    Fife CM; McCarroll JA; Kavallaris M, 2017, 'Movers and shakers: cell cytoskeleton in cancer metastasis (vol 171, pg 5507, 2014)', BRITISH JOURNAL OF PHARMACOLOGY, 174, pp. 116 - 116,
    Journal articles | 2017
    Fife CM; Sagnella SM; Teo WS; Po'uha ST; Byrne FL; Yeap YY; Ng DC; Davis TP; McCarroll JA; Kavallaris M, 2017, 'Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration.', Oncogene, 36, pp. 501 - 511,
    Journal articles | 2017
    Kunz-Schughart LA; Dubrovska A; Peitzsch C; Ewe A; Aigner A; Schellenburg S; Muders MH; Hampel S; Cirillo G; Iemma F; Tietze R; Alexiou C; Stephan H; Zarschler K; Vittorio O; Kavallaris M; Parak WJ; Mädler L; Pokhrel S, 2017, 'Nanoparticles for radiooncology: Mission, vision, challenges', Biomaterials, 120, pp. 155 - 184,
    Journal articles | 2017
    Lovelace MD; Powter EE; Coleman PR; Zhao Y; Parker A; Chang GH; Lay AJ; Hunter J; McGrath AP; Jormakka M; Bertolino P; McCaughan G; Kavallaris M; Vadas MA; Gamble JR, 2017, 'The RhoGAP protein ARHGAP18/SENEX localizes to microtubules and regulates their stability in endothelial cells', Molecular Biology of the Cell, 28, pp. 1066 - 1078,
    Journal articles | 2017
    Oliver S; Jofri A; Thomas DS; Vittorio O; Kavallaris M; Boyer C, 2017, 'Tuneable catechin functionalisation of carbohydrate polymers', Carbohydrate Polymers, 169, pp. 480 - 494,
    Journal articles | 2017
    Parker AL; Teo WS; McCarroll JA; Kavallaris M, 2017, 'An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance', International Journal of Molecular Sciences, 18, pp. 1434,
    Journal articles | 2017
    Wojciechowski JP; Martin AD; Mason AF; Fife CM; Sagnella SM; Kavallaris M; Thordarson P, 2017, 'Choice of Capping Group in Tripeptide Hydrogels Influences Viability in the Three-Dimensional Cell Culture of Tumor Spheroids', ChemPlusChem, 82, pp. 383 - 389,
    Journal articles | 2016
    Byrne FL; McCarroll JA; Kavallaris M, 2016, 'Analyses of tumor burden in vivo and metastasis ex vivo using luciferase-expressing cancer cells in an orthotopic mouse model of neuroblastoma', RNA imaging: methods and protocols, 1372, pp. 61 - 77,
    Journal articles | 2016
    Ercole F; Mansfeld FM; Kavallaris M; Whittaker MR; Quinn JF; Halls ML; Davis TP, 2016, 'Macromolecular Hydrogen Sulfide Donors Trigger Spatiotemporally Confined Changes in Cell Signaling', Biomacromolecules, 17, pp. 371 - 383,
    Journal articles | 2016
    Levrier C; Sadowski MC; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Nelson CC, 2016, '6α-Acetoxyanopterine: A novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells', Molecular Cancer Therapeutics, 16, pp. 3 - 15,
    Journal articles | 2016
    Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T, 2016, 'The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs', Oncotarget, 7, pp. 79217 - 79232,
    Journal articles | 2016
    McCarroll JA; Teo J; Boyer C; Youkhana J; Sagnella S; Duong H; Sharbeen G; Goldstein D; Davis T; Kavallaris M; Phillips P; Liu J, 2016, 'A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo.', Biomacromolecules, 17, pp. 2337 - 2351,
    Journal articles | 2016
    McCarroll JA; Teo W; Kavallaris M; Byrne F; Davis T, 2016, 'Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration', Oncogene, 36, pp. 501 - 511,
    Journal articles | 2016
    Oliver S; Thomas DS; Kavallaris M; Vittorio O; Boyer C, 2016, 'Efficient functionalisation of dextran-aldehyde with catechin: potential applications in the treatment of cancer', Polymer Chemistry,
    Journal articles | 2016
    Parker AL; Turner N; McCarroll JA; Kavallaris M, 2016, 'βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells', Carcinogenesis, 37, pp. 787 - 798,
    Journal articles | 2016
    Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD, 2016, 'Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study', EBioMedicine, 6, pp. 87 - 95,
    Journal articles | 2016
    Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia (United States), 18, pp. 753 - 764,
    Journal articles | 2016
    Vittorio O; Brandl M; Cirillo G; Kimpton K; Hinde E; Gaus K; Yee E; Kumar N; Duong H; Fleming C; Haber M; Norris M; Boyer C; Kavallaris M, 2016, 'Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth', Oncotarget, 7, pp. 47479 - 47493,
    Journal articles | 2016
    Vittorio O; Cojoc M; Curcio M; Spizzirri UG; Hampel S; Nicoletta FP; Iemma F; Dubrovska A; Kavallaris M; Cirillo G, 2016, 'Polyphenol Conjugates by Immobilized Laccase: The Green Synthesis of Dextran-Catechin', Macromolecular Chemistry and Physics, 217, pp. 1488 - 1492,
    Journal articles | 2015
    Cheung BB; Tan O; Koach J; Liu B; Shum MSY; Carter DR; Sutton S; Po'uha ST; Chesler L; Haber M; Norris MD; Kavallaris M; Liu T; O'Neill GM; Marshall GM, 2015, 'Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma', Molecular Oncology, 9, pp. 1484 - 1500,
    Journal articles | 2015
    Kavallaris M; Po'uha S, 2015, 'Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cells', Cell Cycle, 14, pp. 3908 - 3919,
    Journal articles | 2015
    Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T, 2015, 'Erratum: Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression (Journal of the National Cancer Institute (2014) 106:7 (dju113) DOI: 10.1093/jnci/dju113)', Journal of the National Cancer Institute, 107,
    Journal articles | 2015
    Makharza S; Vittorio O; Cirillo G; Oswald S; Hinde E; Kavallaris M; Büchner B; Mertig M; Hampel S, 2015, 'Graphene oxide - Gelatin nanohybrids as functional tools for enhanced carboplatin activity in neuroblastoma cells', Pharmaceutical Research, 32, pp. 2132 - 2143,
    Journal articles | 2015
    McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M, 2015, 'Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer', Oncotarget, 6, pp. 12020 - 12034,
    Journal articles | 2015
    McCarroll JA; Gan PP; Erlich RB; Liu M; Dwarte T; Sagnella SS; Akerfeldt MC; Yang L; Parker AL; Chang MH; Shum MS; Byrne FL; Kavallaris M; Sagnella S, 2015, 'TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer', Cancer Research, 75, pp. 415 - 425,
    Journal articles | 2015
    McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M; Johns AL; Biankin AV; Kavallaris M; Phillips PA; Johns A, 2015, 'βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer', Oncotarget, 6, pp. 2235 - 2249,
    Journal articles | 2015
    Pasquier E; Tuset MP; Sinnappan S; Carnell M; Macmillan A; Kavallaris M, 2015, 'γ-Actin plays a key role in endothelial cell motility and neovessel maintenance', Vascular Cell, 7,
    Journal articles | 2015
    Sevimli S; Sagnella S; Macmillan A; Whan R; Kavallaris M; Bulmus V; Davis TP, 2015, 'The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymers', Biomaterials Science, 3, pp. 323 - 335,
    Journal articles | 2014
    Brandl MB; Pasquier E; Li F; Beck D; Zhang S; Zhao H; Kavallaris M; Wong STC, 2014, 'Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer', Molecular Oncology, 8, pp. 1548 - 1560,
    Journal articles | 2014
    Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M, 2014, 'RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model', Oncogene, 33, pp. 882 - 890,
    Journal articles | 2014
    Chen X; Cheng X; Soeriyadi AH; Sagnella SM; Lu X; Scott JA; Lowe SB; Kavallaris M; Gooding JJ, 2014, 'Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli', Biomaterials Science, 2, pp. 121 - 130,
    Journal articles | 2014
    Chen X; Soeriyadi AH; Lu X; Sagnella SM; Kavallaris M; Gooding JJ, 2014, 'Dual bioresponsive mesoporous silica nanocarrier as an "AND" logic gate for targeted drug delivery cancer cells', Advanced Functional Materials, 24, pp. 6999 - 7006,
    Journal articles | 2014
    Eiffe E; Pasquier E; Kavallaris M; Herbert C; Black DSC; Kumar N, 2014, 'Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes', Bioorganic and Medicinal Chemistry, 22, pp. 5182 - 5193,
    Journal articles | 2014
    Fife CM; McCarroll JA; Kavallaris M, 2014, 'Movers and shakers: Cell cytoskeleton in cancer metastasis', British Journal of Pharmacology, 171, pp. 5507 - 5523,
    Journal articles | 2014
    Kim PY; Tan O; Diakiw SM; Carter D; Sekerye EO; Wasinger VC; Liu T; Kavallaris M; Norris MD; Haber M; Chesler L; Dolnikov A; Trahair TN; Cheung NK; Marshall GM; Cheung BB; Sekyere E, 2014, 'Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach', Journal of Proteomics, 96, pp. 1 - 12,
    Journal articles | 2014
    Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T, 2014, 'Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression', Journal of the National Cancer Institute, 106, pp. dju113,
    Journal articles | 2014
    McCarroll J; Teo J; Boyer C; Goldstein D; Kavallaris M; Phillips PA, 2014, 'Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer', Frontiers in Physiology, 5, pp. 1 - 10,
    Journal articles | 2014
    McCarroll JA; Naim S; Sharbeen G; Russia N; Lee J; Kavallaris M; Goldstein D; Phillips PA, 2014, 'Role of pancreatic stellate cells in chemoresistance in pancreatic cancer', Frontiers in Physiology, 5 APR, pp. 141,
    Journal articles | 2014
    Parker AL; Kavallaris M; McCarroll JA, 2014, 'Microtubules and their role in cellular stress in cancer', Frontiers in Oncology, 4 JUN, pp. 153,
    Journal articles | 2014
    Sagnella SM; Hien D; MacMillan A; Boyer C; Whan R; McCarroll JA; Davis TP; Kavallaris M; Duong H, 2014, 'Dextran-Based Doxorubicin Nanocarriers with Improved Tumor Penetration', BIOMACROMOLECULES, 15, pp. 262 - 275,
    Journal articles | 2014
    Sagnella SM; McCarroll JA; Kavallaris M, 2014, 'Drug delivery: Beyond active tumour targeting', Nanomedicine: Nanotechnology, Biology, and Medicine,
    Journal articles | 2014
    Sagnella SM; McCarroll JA; Kavallaris M, 2014, 'Drug delivery: Beyond active tumour targeting', Nanomedicine: Nanotechnology, Biology, and Medicine, 10, pp. 1131 - 1137,
    Journal articles | 2014
    Vittorio O; Brandl M; Cirillo G; Spizzirri UG; Picci N; Kavallaris M; Iemma F; Hampel S, 2014, 'Novel functional cisplatin carrier based on carbon nanotubes-quercetin nanohybrid induces synergistic anticancer activity against neuroblastoma in vitro', RSC Advances, 4, pp. 31378 - 31384,
    Journal articles | 2014
    Vittorio O; Voliani V; Faraci P; Karmakar B; Iemma F; Hampel S; Kavallaris M; Cirillo G, 2014, 'Magnetic catechin-dextran conjugate as targeted therapeutic for pancreatic tumour cells', Journal of Drug Targeting, 22, pp. 408 - 415,
    Journal articles | 2013
    Basuki JS; Duong HTT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP, 2013, 'Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release', ACS NANO, 7, pp. 10175 - 10189,
    Journal articles | 2013
    Bell JL; Malyukova A; Kavallaris M; Marshall GM; Cheung BB, 2013, 'TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization', Cell Cycle, 12, pp. 889 - 898,
    Journal articles | 2013
    Boyer CA; Kavallaris M; Whan R; Macmillan A, 2013, 'Functionalizing biodegradable dextran scaffolds using living radical polymerization: New versatile nanoparticles for the delivery of therapeutic molecules', Molecular Pharmaceutics, 9, pp. 3046 - 3061,
    Journal articles | 2013
    Duong HTT; Kamarudin ZM; Erlich RB; Li Y; Jones MJ; Kavallaris M; Boyer CA; Davis TP, 2013, 'Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers', Chemical Communications, 49, pp. 4190 - 4192,
    Journal articles | 2013
    Pasquier E; Street J; Pouchy C; Carre M; Gifford AJ; Murray J; Norris MD; Trahair T; Andre N; Kavallaris M, 2013, 'B-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma', British Journal of Cancer, 108, pp. 2485 - 2494,
    Journal articles | 2013
    Pasquier E; Trahair T; Kavallaris M; Andre N, 2013, 'Reply: Comment on 'beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'-β- blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs', British Journal of Cancer, 109, pp. 2024 - 2025,
    Journal articles | 2013
    Pasquier E; Tuset MP; Street J; Sinnappan SM; Mackenzie KL; Braguer D; Andre N; Kavallaris M, 2013, 'Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells', Angiogenesis, 16, pp. 373 - 386,
    Journal articles | 2013
    Po'uha ST; Honore S; Braguer D; Kavallaris M, 2013, 'Partial depletion of gamma-actin suppresses microtubule dynamics', Cytoskeleton, 70, pp. 148 - 160,
    Journal articles | 2013
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP, 2013, 'Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery', Biomacromolecules, 14, pp. 4135 - 4149,
    Journal articles | 2013
    Teo J; Erlich RB; Sagnella S; Dwarte T; Davis TP; Kavallaris M; McCarroll J; Boyer C; Duong HTT; Phillips P; Sharbeen G; Goldstein D, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, 10, pp. 2435 - 2444,
    Journal articles | 2012
    Bell J; Malyukova A; Holien J; Koach J; Parker M; Kavallaris M; Marshall GM; Cheung BB, 2012, 'TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members', PLoS One, 7, pp. Article number e37470,
    Journal articles | 2012
    Cheung BB; Koach J; Tan O; Kim P; Bell J; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris MD; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott J; Cooper C; Halliday GM; Scolyer RA; Marshall GM, 2012, 'The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro', Journal of Pathology, 226, pp. 451 - 462,
    Journal articles | 2012
    Failes TW; Mitic G; Abdel-halim H; Po'uha ST; Liu M; Hibbs DE; Kavallaris M, 2012, 'Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells', PLoS ONE, 7, pp. e30734,
    Journal articles | 2012
    Kan C; Wen VW; Pasquier E; Jankowski K; Chang M; Richards LA; Kavallaris M; Mackenzie K, 2012, 'Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization', Oncogene, 31, pp. 4815 - 4827,
    Journal articles | 2012
    Mccarroll JA; Baigude H; Erlich R; Dwarte T; Rana TM; Kayallaris M, 2012, 'Silencing alll-tubulin by RNA interfering nanoparticles in non-small cell lung cancer', CANCER RESEARCH, 72,
    Journal articles | 2012
    Sevimli S; Sagnella SM; Kavallaris M; Bulmus V; Davis TP, 2012, 'Synthesis, self-assembly and stimuli responsive properties of cholesterol conjugated polymers', Polymer Chemistry, 3, pp. 2057 - 2069,
    Journal articles | 2011
    Gan PP; Mccarroll J; Byrne F; Garner J; Kavallaris M, 2011, 'Specific beta-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells', PLoS One, 6, pp. e21717,
    Journal articles | 2011
    Ginu A; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V, 2011, 'Block Co-polymer Nanoparticles with Degradable Cross-Linked Core and Low-Molecular-Weight PEG Corona for Anti-tumour Drug Delivery', Journal of Biomaterials Science - Polymer Edition, 22, pp. 1001 - 1022,
    Journal articles | 2011
    Katsetos CD; Draber P; Kavallaris M, 2011, 'Targeting betaIII-tubulin in glioblastoma multiforme: From cell biology and histopathology to cancer therapeutics', Anti-Cancer Agents in Medicinal Chemistry, 11, pp. 719 - 728,
    Journal articles | 2011
    Kow SC; McCarroll J; Valade D; Boyer CA; Dwarte T; Davis TP; Kavallaris M; Bulmus V, 2011, 'Dicer-Labile PEG Conjugates for siRNA Delivery', Biomacromolecules, 12, pp. 4301 - 4310,
    Journal articles | 2011
    Nakano M; Saldanha R; Gobel A; Kavallaris M; Packer NH, 2011, 'Identification of Glycan Structure Alterations on Cell Membrane Proteins in Desoxyepothilone B Resistant Leukemia Cells', Molecular and Cellular Proteomics, 10,
    Journal articles | 2011
    Pasquier E; Ciccolini J; Carre M; Giacometti S; Fanciullino R; Pouchy C; Montero MP; Serdjebi C; Kavallaris M; Andre N, 2011, 'Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.', Oncotarget, 2, pp. 797 - 809
    Journal articles | 2011
    Schofield DJ; Meachem S; West C; Kavallaris M; Callander EJ, 2011, 'A crisis in the making? Education, ageing populations and the future of the medical research workforce', Medical Education, 45, pp. 200 - 207,
    Journal articles | 2011
    Shum M; Pasquier E; Po'uha ST; O'Neill GM; Chaponnier C; Gunning PW; Kavallaris M, 2011, 'γ-Actin regulates cell migration and modulates the ROCK signaling pathway', The FASEB Journal, 25, pp. 4423 - 4433
    Journal articles | 2011
    Wong L; Kavallaris M; Bulmus V, 2011, 'Doxorubicin conjugated, crosslinked, PEGylated particles prepared via one-pot thiol-ene modification of a homopolymer scaffold: synthesis and in vitro evaluation', Polymer Chemistry, 2, pp. 385 - 393,
    Journal articles | 2010
    Abraham G; McCaroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V, 2010, 'Block Co-polymer Nanoparticles with Degradable Cross-Linked Core and Low-Molecular-Weight PEG Corona for Anti-tumour Drug Delivery', Journal of Biomaterials Science - Polymer Edition, 22, pp. 1001 - 1022,
    Journal articles | 2010
    Boyer CA; Priyanto P; Davis TP; Pissuwan D; Bulmus V; Kavallaris M; Teoh WY; Amal R; Carroll M; Woodward R; St pierre T, 2010, 'Anti-fouling magnetic nanoparticles for siRNA delivery', Journal of Materials Chemistry, 20, pp. 255 - 265,
    Journal articles | 2010
    Gan PP; McCarroll JA; Po'uha S; Kamath K; Jordan MA; Kavallaris M, 2010, 'Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of beta III-Tubulin', Molecular Cancer Therapeutics, 9, pp. 1339 - 1348,
    Journal articles | 2010
    Kavallaris M, 2010, 'Erratum: Microtubules and resistance to tubulin-binding agents (Nature Reviews Cancer)', Nature Reviews Cancer, 10, pp. 309,
    Journal articles | 2010
    Kavallaris M, 2010, 'Microtubules and resistance to tubulin-binding agents', NATURE REVIEWS CANCER, 10,
    Journal articles | 2010
    Kavallaris M, 2010, 'Microtubules and resistance to tubulin-binding agents', Nature Reviews Cancer,
    Journal articles | 2010
    Kavallaris M, 2010, 'Microtubules and resistance to tubulin-binding agents', Nature Reviews Cancer, 10, pp. 194 - 204,
    Journal articles | 2010
    Liu T; Bell J; Koach J; Malyukova A; Thomas W; Sekyere E; Cunningham A; Norris M; Haber M; Kavallaris M; Cheung B-B; Kim P; Tan O; Marshall G, 2010, 'TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells', Oncogene, 29, pp. 6172 - 6183,
    Journal articles | 2010
    McCarroll J; Gan PP; Liu M; Kavallaris M, 2010, 'beta III-Tubulin Is a Multifunctional Protein Involved in Drug Sensitivity and Tumorigenesis in Non-Small Cell Lung Cancer', Cancer research, 70, pp. 4995 - 5003,
    Journal articles | 2010
    Pasquier E; Kavallaris M; Andre N, 2010, 'Metronomic chemotherapy: new rationale for new directions', Nature Reviews Clinical Oncology, 7, pp. 455 - 465,
    Journal articles | 2010
    Pasquier E; Sinnappan S; Munoz M; Kavallaris M, 2010, 'ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties', Molecular Cancer Therapeutics, 9, pp. 1408 - 1418,
    Journal articles | 2010
    Po'uha S; Shum MSY; Goebel A; Bernard O; Kavallaris M, 2010, 'LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs', Oncogene, 29, pp. 597 - 607,
    Journal articles | 2009
    Liu T, 2009, 'The cyclin-dependent kinase inhibitor, p21WAF1, promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells', Carcinogenesis, 30, pp. 1865 - 1871,
    Journal articles | 2009
    Raif A; Marshall GM; Bell J; Koach J; Tan O; D'andreti C; Thomas WD; Sekyere E; Norris MD; Haber M; Kavallaris M; Cheung BB, 2009, 'The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation', Cancer Letters, 277, pp. 82 - 90,
    Journal articles | 2008
    Chan YK; Wong TH; Byrne F; Kavallaris M; Bulmus V, 2008, 'Acid-labile core cross-linked micelles for pH-triggered release of antitumor drugs.', Biomacromolecules, 9, pp. 1826 - 1836,
    Journal articles | 2008
    Gan PP; Kavallaris M, 2008, 'Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb beta-Tubulin in Vinca Alkaloid Sensitivity', Cancer research, 68, pp. 9817 - 9824
    Journal articles | 2008
    Kavallaris M; Annereau JP; Barret JM, 2008, 'Potential Mechanisms of Resistance to Microtubule Inhibitors', Seminars in Oncology, 35,
    Journal articles | 2008
    Kavallaris M; Meachem S; Hulett M; West C; Pitt R; Chesters J; Laffan W; Boreham P; Khachigian LM, 2008, 'Perceptions in health and medical research careers: the Australian Society for Medical Research Workforce Survey', Medical Journal of Australia, 188, pp. 520 - 524
    Journal articles | 2008
    Liaw TY; Salam N; McKay M; Cunningham AM; Hibbs D; Kavallaris M, 2008, 'Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions', Molecular Cancer Therapeutics, 7, pp. 3150 - 3159
    Journal articles | 2008
    Michaud J; Simpson KM; Escher R; Buchet-Poyau K; Beissbarth T; Carmichael CA; Ritchie M; Schutz F; Cannon P; Liu M; Shen XF; Ito Y; Raskind WH; Horwitz MS; Osato M; Turner DR; Speed TP; Kavallaris M; Smyth GK; Scott HS, 2008, 'Integrative analysis of RUNX1 downstream pathways and target genes.', BMC Genomics, 8, pp. 363
    Journal articles | 2008
    Ong V; Liem N; Schmid M; Verrills NM; Papa R; Marshall GM; Mackenzie K; Kavallaris M; Lock RB, 2008, 'A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts', Journal of Pharmacology and Experimental Therapeutics, 324, pp. 434 - 442,
    Journal articles | 2008
    Pasquier E; Kavallaris M, 2008, 'Microtubules: A dynamic target in cancer therapy', IUBMB Life, 60, pp. 165 - 170,
    Journal articles | 2007
    Escher R; Wilson P; Carmichael CA; Suppiah R; Liu M; Kavallaris M; Cannon P; Michaud J; Scott HS, 2007, 'A pedigree with autosomal dominant thrombocytopenia, red cell macrocytosis, and an occurrence of t(12:21) positive pre-B acute lymphoblastic leukemia', Blood Cells Molecules and Diseases, 39, pp. 107 - 114
    Journal articles | 2007
    Gan PP; Pasquier E; Kavallaris M, 2007, 'Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer', Cancer research, 67, pp. 9356 - 9363
    Journal articles | 2007
    Kavallaris M, 2007, 'Tubulin/microtubule system as an anti-cancer drug target', Current Cancer Drug Targets, 7, pp. 696,
    Journal articles | 2007
    Liaw TY; Chang MH; Kavallaris M, 2007, 'The cytoskeleton as a therapeutic target in childhood acute leukemia: obstacles and opportunities', Current Drug Targets, 8, pp. 739 - 749
    Journal articles | 2007
    Tommasi S; Mangia A; Lacalamita R; Bellizzi A; Fedele V; Chiriatti A; Thomssen C; Kendzierski N; Latorre A; Lorusso V; Schittulli F; Zito F; Kavallaris M; Paradiso A, 2007, 'Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of Beta-tubulins', International Journal of Cancer, 120, pp. 2078 - 2085
    Journal articles | 2006
    Butt A; Roberts CG; Seavvright A; Oelrichs P; Macleod JK; Liaw TY; Kavallaris M; Somers-Edgar T; Lehrbach GM; Watts CK; Sutherland RL, 2006, 'A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells', Molecular Cancer Therapeutics, 5, pp. 2300 - 2309
    Journal articles | 2006
    Chan YK; Bulmus V; Zareie MH; Barner L; Kavallaris M; Byrne F, 2006, 'Acid-Cleavable polymeric core-shell particles for delivery of hydrophoblic drugs', Journal of Controlled Release, 115, pp. 197 - 207
    Journal articles | 2006
    Cheung BB; Bell J; Raif A; Bohlken A; Yan J; Poljak A; Smith S; Lee M; Thomas WD; Kavallaris M; Norris MD; Haber M; Liu H; Zajchowski D; Marshall GM; bell , 2006, 'The estrogen-responsive B box protein is a novel regulator of the retinoid signal', The Journal of Biological Chemistry, 281, pp. 18246 - 18256
    Journal articles | 2006
    Kavallaris M, 2006, 'Discovering novel strategies for antimicrotubule cytotoxic therapy', EJC Supplements, 4, pp. 3 - 9
    Journal articles | 2006
    Pouha ST; Liu M; Marshall GM; Kavallaris M; Verrills NM, 2006, 'Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia', Journal of the National Cancer Institute, 98, pp. 1363 - 1374
    Journal articles | 2006
    Verrills NM; Liaw TY; Lock RB; Kavallaris M; Liem N; Hood B, 2006, 'Proteomic anlaysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia - an in vivo study', Proteomics, 6, pp. 1681 - 1694
    Journal articles | 2005
    Kavallaris M; Marshall GM, 2005, 'Proteomics and disease: opportunities and challenges', Medical Journal of Australia, 182, pp. 575 - 579
    Journal articles | 2005
    Schevzov G; Vrhovski B; Bryce N; Elmir S; Qiu M; O''neill G; Yang N; Verrills N; Kavallaris M; Gunning P, 2005, 'Tissue-specific tropomyosin isoform composition.', Histochemical Journal, 53, pp. 557 - 570,
    Journal articles | 2005
    Verrills NM; Kavallaris M, 2005, 'Improving the targeting of tubulin-binding agents: lessons from drug resistance studies', Current Pharmaceutical Design, 11, pp. 1719 - 1733
    Journal articles | 2005
    Verrills NM; Kavallaris M, 2005, 'Improving the targeting of tubulin-binding agents: lessons from drug resistance studies.', Current Pharmaceutical Design, 11, pp. 1719 - 1733
    Journal articles | 2004
    Don S; Verrills NM; Liaw T; Haber M; Norris MD; Kavallaris M, 2004, 'Neuronal-associated microtubule proteins class III B-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs.', Molecular Cancer Therapeutics, 3, pp. 1137 - 1146
    Journal articles | 2003
    Burkhart CA; Cheng AJ; Madafiglio J; Kavallaris M; Mili M; Marshall GM; Weiss WA; Khachigian LM; Norris MD; Haber M, 2003, 'Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma', Journal of National Cancer Institute, 95, pp. 1394 - 1403
    Journal articles | 2003
    Cheung BB; Yan JX; Smith SA; Nguyen TG; Lee M; Kavallaris M; Norris MD; Haber M; Marshall GM, 2003, 'Growth inhibitory retinoid effects after recruitment of retinoid X receptor B to the retinoic acid receptor B promoter', International Journal of Cancer, 105, pp. 856 - 867
    Journal articles | 2003
    Verrills NM; Flemming C; Liu M; Ivery M; Cobon GS; Norris MD; Haber M; Kavallaris M, 2003, 'Microtubule alterations and mutations induced by desoxyepothilone B: Implications for drug-target', Chemistry and biology, 10, pp. 597 - 607
    Journal articles | 2003
    Verrills NM; Kavallaris M, 2003, 'Drug Resistance Mechanisms in Cancer Cells: A Proteomics Perspective', Current Opinion in Molecular Therapeutics, 5, pp. 258 - 265
    Journal articles | 2003
    Verrills NM; Walsh B; Cobons GS; Hains P; Kavallaris M, 2003, 'Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukaemia reveals novel cytoskeletal alternations', The Journal of Biological Chemistry, 278, pp. 45082 - 45093,
    Journal articles | 2002
    Don S; Kavallaris M, 2002, 'Microtubule alterations and resostance to tubulin-binding agents', International Journal of Oncology, 21, pp. 621 - 628
    Journal articles | 2002
    Kavallaris M; Verrills NM; Hill B, 2002, 'Anticancer therapy with novel tubulin-interacting drugs', Drug Resistance Updates, 4, pp. 392 - 401,
    Journal articles | 2001
    Kavallaris M; Burkhart CA; Horwitz SB, 2001, 'The role of beta-tubulin isotypes in resistance to antimitotic drugs', Biochimica et Biophysica ACTA, 1471, pp. 1 - 9,
    Journal articles | 2001
    Kavallaris M; Tait AS; Norris MD; Haber M; Walsh B; He L; Horwitz SB, 2001, 'Multiple microtubule alterations are associated with vinca alkaloid resistance in human leukemia cells', Cancer research, pp. 5803 - 5809
    Journal articles | 2001
    Tait AS; Kavallaris M; etievant C; Unkown A; Barret J; Hill B, 2001, 'Markedly diminished drug-resistance including properties of vinflunine (20`, 20`- difluro- 3`, 4` - dihydrovinorelbine) relative tovinorelbine, identified in murine and human tumour cells in vivo and in vitro, with clinical implications', Cancer Chemotherapy and Pharmacology, 48, pp. 62 - 70,
    Journal articles | 2000
    Murphy KD; Ranganathan V; Farnsworth ML; Kavallaris M; Lock RB, 2000, 'Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumour cells', Cell death and differentiation, pp. 102 - 111
    Journal articles | 1999
    Haber M; Bordow SB; Gilbert J; Madafiglio J; Kavallaris M; Marshall GM; Mechetner EB; Fruehauf JP; Tee L; Cohn S; Salwen H; Schmidt ML; Norris MD; Gilbert J, 1999, 'Altered expression of the MYCN Oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells', Oncogene, 18, pp. 2777 - 2782
    Journal articles | 1999
    Kavallaris M; Burkhart CA; Horwitz SB, 1999, 'Antisense oligonucleotides to class III B-tubulin sensitise drug-resistant cells to Taxol.', British Journal of Cancer, 80, pp. 1020 - 1025,
    Journal articles | 1998
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD, 1998, 'P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in Methotrexate accumulation due to a point mutation in the reduced folate carrier gene', International Journal of Cancer, pp. 176 - 181
    Journal articles | 1998
    Kavallaris M; Gardaneh M; Cheung BB; Camacho M; Hocker JE; Norris MD; Haber M; Marshall GM, 1998, 'In Vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells', Anticancer Research, pp. 1793 - 1798
    Journal articles | 1997
    Kavallaris M; Kuo DY; Burkhart CA; Regl DL; Norris MD; Haber M; Horwitz SB, 1997, 'TAXOL-RESISTANT EPITHELIAL OVARIAN TUMORS ARE ASSOCIATED WITH ALTERED EXPRESSION OF SPECIFIC {BETA}-TUBLIN ISOTYPES', Journal of Clinical Investigation, 100, pp. 1282 - 1293
    Journal articles | 1997
    Kavallaris M, 1997, 'The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance', Anti-Cancer Drugs, 8, pp. 17 - 25,
    Journal articles | 1997
    Norris MD; Bordow SB; Haber PS; Marshall GM; Kavallaris M; Madafiglio J; Cohn S; Schmidt ML; Hipfner DR; Deeley RG; Cole SP; Haber M; Salwen H, 1997, 'EVIDENCE THAT THE N-MYC ONCOGENE REGULATES MRP GENE EXPRESSION IN NEUROBLASTOMA', European Journal of Cancer, pp. 1911 - 1916
    Journal articles | 1996
    Kavallaris M; Leary JA; Barrett JA; Friedlander ML, 1996, 'MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors', Cancer Letters, 102, pp. 7 - 16,
    Journal articles | 1996
    Norris MD; De Graaf D; Haber M; Kavallaris M; Madafiglio J; Gilbert J; Kwan E; Stewart BW; Mechetner EB; Gudkov AV; Roninson IB, 1996, 'Involvement of MDR1 P-Glycoprotein in multifactorial resistance to methotrexate', International Journal of Cancer, pp. 613 - 619
    Journal articles | 1995
    Haber M; Norris MD; Kavallaris M; Camacho M; Madafiglio J; Baker C; White L; Stewart BW, 1995, 'An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro', Cancer Letters, pp. 49 - 55
    Journal articles | 1994
    Norris MD; Haber M; Gilbert J; Kavallaris M; Marshall GM; Stewart BW, 1994, 'N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction.', Progress in clinical and biological research, 385, pp. 27 - 33
    Journal articles | 1993
    Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW, 1993, 'Determination of n-myc gene amplification in neuroblastoma by differential polymerase chain reaction', Molecular and Cellular Probes, 7, pp. 227 - 234,
    Journal articles | 1993
    Kavallaris M; Madafiglio J; Norris MD; Haber M, 1993, 'Resistance to Tetracycline, a Hydrophilic Antibiotic, Is Mediated by P-Glycoprotein in Human Multidrug-Resistant Cells', Biochemical and Biophysical Research Communications, 190, pp. 79 - 85,
    Journal articles | 1993
    Pittman SM; Kavallaris M; Stewart BW, 1993, 'Karyotypic analysis of CCRF-CEM and drug-resistant cell lines with stable and unstable ploidy', Cancer Genetics and Cytogenetics, 66, pp. 54 - 62,
    Journal articles | 1992
    TELFORD DJ; KAVALLARIS M; WHITE L; NORRIS MD; BRIAN MJ; STEWART BW, 1992, 'Association of N‐myc amplification with neuroblastoma: The Australian and New Zealand experience', Journal of Paediatrics and Child Health, 28, pp. 58 - 63,
    Journal articles | 1991
    Kavallaris M; Haber M; Norris MD; Matherly LH; Stewart BW, 1991, 'Characterization of Mechanisms Mediating Drug Resistance in Human Leukemic Cells Selected with High Concentration Methotrexate', Pteridines, 3, pp. 119 - 121,
    Journal articles | 1991
    Norris MD; Haber M; Kavallaris M; Brian MJ; Lutze LH; White L; Stewart BW, 1991, 'Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T‐cell leukemia xenograft, LALW‐2', Cancer, 68, pp. 981 - 987, http://dx.doi.org/10.1002/1097-0142(19910901)68:5<981::AID-CNCR2820680512>3.0.CO;2-W
    Journal articles | 1991
    Stewart BW; Kavallaris M; Catchpoole D; Norris MD, 1991, 'Two classes of single-stranded regions evident in deproteinized preparations of replicating DNA isolated from mammalian cells', Experimental Cell Research, 192, pp. 639 - 642,
    Journal articles | 1990
    Kavallaris M; Haber M; Norris MD; Pittman SM; Reed C; Stewart BW, 1990, 'Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration', Cancer Letters, 51, pp. 193 - 201,
    Journal articles | 1989
    Haber M; Norris MD; Kavallaris M; White L; Stewart BW; Bell DR; Davey RA, 1989, 'Atypical Multidrug Resistance in a Therapy-induced Drug-resistant Human Leukemia Cell Line (LALW-2): Resistance to Vinca Alkaloids Independent of P-Glycoprotein', Cancer Research, 49, pp. 5281 - 5287
    Journal articles | 1989
    Haber M; Reed C; Kavallaris M; Norris MD; Stewart BW, 1989, 'Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate', Journal of the National Cancer Institute, 81, pp. 1250 - 1254,
    Journal articles | 1986
    HABER M; KAVALLARIS M; STEWART BW, 1986, '2-STAGE INCORPORATION OF THYMIDINE TRIPHOSPHATE INTO MAMMALIAN DNA AS INDICATED BY CHROMATOGRAPHY ON BENZOYLATED DEAE-CELLULOSE', JOURNAL OF CHROMATOGRAPHY, 382, pp. 127 - 134,
    Journal articles | 1986
    Haber M; Kavallaris M; Stewart BW, 1986, 'Two-stage incorporation of thymidine triphosphate into mammalian DNA as indicated by chromatography on benzoylated DEAE-cellulose', Journal of Chromatography - Biomedical Applications, Vol. 382, pp. 127 - 134
    Journal articles | 1986
    Haber M; Kavallaris M; Stewart BW, 1986, 'Two-stage incorporation of thymidine triphosphate into mammalian DNA as indicated by chromatography on benzoylated DEAE-cellulose', Journal of Chromatography B: Biomedical Sciences and Applications, 382, pp. 135 - 145,
  • Conference Abstracts | 2023
    Lock RB; Mohamed SMA; Schofield P; Friedrich K-H; Christ D; Kavallaris M; Bayat N, 2023, 'Abstract B134: Targeting Philadelphia chromosome-like acute lymphoblastic leukemia with a novel CRLF2 antibody fragment-drug conjugate', in Molecular Cancer Therapeutics, American Association for Cancer Research (AACR), Vol. 22, pp. B134 - B134,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Data from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Data from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, ,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S1 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S1 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S2 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S2 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S3 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S3 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, ,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S4 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S4 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S5 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S5 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S6 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S6 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, ,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S7 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Figure S7 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, ,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Master Regulator Analysis from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Other | 2023
    Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2023, Master Regulator Analysis from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion,
    Preprints | 2022
    Du E; Jung M; Skhinas J; Tolentino M; Jamshidi N; Houng J; Tjandra K; Engel M; Utama R; Tilley R; Kavallaris M; Gooding J, 2022, A 3D bioprintable hydrogel with tuneable stiffness for exploring cells encapsulated in matrices of differing stiffnesses,
    Preprints | 2022
    Kokkinos J; Sharbeen G; Ignacio RM; Pandzic E; Youkhana J; Boyer C; Haghighi K; Gunawarman M; Goldstein D; Gebski V; Pajic M; Pitiyarachchi O; Davis M; Schulstad G; Arkell OSM; Kopecky C; Gonzales-Aloy E; Erkan M; Morton J; Kavallaris M; Gunning P; Hardeman E; Johns A; Gill A; Whan R; Mawson A; McCarroll J; Phillips P; Australian Pancreatic Cancer Genome Initiative , 2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer,
    Preprints | 2021
    Ahmed-Cox A; Pandzic E; Johnston S; Heu C; McGhee J; Mansfeld F; Crampin E; Davis T; Whan R; Kavallaris M, 2021, Spatial-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density, ,
    Conference Papers | 2021
    Connerty P; Moles E; deBock C; Jayatilleke N; Smith JL; Meshinchi S; Mayoh C; Kavallaris M; Lock RB, 2021, 'Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for paediatric acute myeloid leukaemia', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH,
    Preprints | 2021
    Jung M; Skhinas J; Du E; Tolentino MAK; Utama R; Engel M; Volkerling A; Sexton A; O’Mahony A; Ribeiro J; Gooding J; Kavallaris M, 2021, A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability,
    Conference Papers | 2020
    Brayford S; Teo WS; Parker A; McVeigh L; McCarroll JA; Kavallaris M, 2020, 'Abstract 1442: Identifying the molecular basis by which βIII-tubulin promotes tumor cell survival and drug resistance in non-small cell lung cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. 1442 - 1442, presented at Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA,
    Conference Papers | 2020
    Ma Z; Esser L; Lai M; Leiske MN; Forgham H; Wong SW; Mansfeld FM; Lewis CR; Davis TP; Quinn J; Phillips P; Kavallaris M; McCarroll JA, 2020, 'Development and Biological Optimization of Star-Shaped Polymeric Nanoparticles for the Delivery of Therapeutic siRNA to Lung Cancer Cells In Vitro and In Vivo', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, pp. 347 - 348, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020,
    Conference Abstracts | 2020
    Mohamed SMA; Sia K; Friedrich K-H; Wohlmann A; Savvides S; Schofield P; Christ D; Kavallaris M; Lock RB; Bayat N, 2020, 'A Novel Engineered Single-Chain Antibody Fragment for Targeting Pediatric Philadelphia Chromosome-like Acute Lymphoblastic Leukemia', in BLOOD, AMER SOC HEMATOLOGY, ELECTR NETWORK, Vol. 136, presented at 62nd Annual Meeting of the American-Society-of-Hematology (ASH), ELECTR NETWORK, 05 December 2020 - 08 December 2020,
    Conference Abstracts | 2020
    Ung C; Tsoli M; Liu J; Cassano D; Upton D; Ehteda A; Mansfield F; Failes T; Kavallaris M; Arndt G; Vittorio O; Voliani V; Cirilo G; Ziegler DS, 2020, 'DDEL-12. NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', in Neuro-Oncology, Oxford University Press (OUP), Vol. 22, pp. iii286 - iii286,
    Conference Papers | 2020
    Ung C; Tsoli M; Liu J; Cassano D; Upton D; Ehteda A; Mansfield F; Failes T; Kavallaris M; Arndt G; Vittorio O; Voliani V; Cirilo G; Ziegler DS, 2020, 'NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, pp. 286 - 286,
    Conference Papers | 2019
    Bailey BJ; Lilja A; Strong C; Moline K; Kavallaris M; Hughes RT; McGhee J, 2019, 'Multi-user immersive virtual reality prototype for collaborative visualization of microscopy image data', in Proceedings - VRCAI 2019: 17th ACM SIGGRAPH International Conference on Virtual-Reality Continuum and its Applications in Industry, ACM Press, presented at The 17th International Conference on Virtual-Reality Continuum and its Applications in Industry, 14 November 2019 - 16 November 2019,
    Conference Papers | 2019
    Grand ML; Kimpton K; Gana C; Valli E; Mayoh C; Kavallaris M, 2019, 'Abstract 3435: Targeting AKT activity inhibits MYCN and sensitizes neuroblastoma to chemotherapeutic agents', in Molecular and Cellular Biology / Genetics, American Association for Cancer Research, pp. 3435 - 3435, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA,
    Conference Abstracts | 2019
    Le Grand M; Kimpton K; Gana C; Valli E; Mayoh C; Kavallaris M, 2019, 'Targeting AKT activity inhibits MYCN and sensitizes neuroblastoma to chemotherapeutic agents', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019,
    Conference Abstracts | 2019
    Pascali G; Parmar A; Voli F; Lerra L; Lee E; Ahmed-Cox A; Kimpton K; Cirillo G; Arthur A; Zahra D; Rahardjo G; Liu G; Lengkeek N; Pellegrini P; Saletta F; Charil A; Kavallaris M; Vittorio O, 2019, '[Cu-64]CuCl2 PET metallomics for determining the anticancer mechanism of novel drug Dextran-Catechin', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, WILEY, Vol. 62, pp. S526 - S527,
    Conference Papers | 2019
    Voli F; Lerra L; Kimpton K; Saletta F; Shen S; Cirillo G; Kavallaris M; Vittorio O, 2019, 'Abstract 3224: Copper homeostasis: A new player in anti-tumor immune response', in Cancer Research, American Association for Cancer Research (AACR), pp. 3224 - 3224,
    Conference Abstracts | 2019
    Voli F; Lerra L; Kimpton K; Saletta F; Shen S; Cirillo G; Kavallaris M; Vittorio O, 2019, 'Copper homeostasis: A new player in anti-tumor immune response', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019,
    Conference Papers | 2018
    Atapattu L; Utama R; O'Mahony A; Fife C; Baek J; Allard T; O'Mahony K; Ribeiro J; Gaus K; Gooding J; Kavallaris M, 2018, 'Precision medicine: High-throughput 3D bioprinting of embedded multicellular cancer spheroids', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018,
    Conference Posters | 2018
    Branchaud D; Muskovic W; Kavallaris M; Filonik D; Bednarz T, 2018, 'Visual microscope for massive genomics datasets, expanded perception and interaction', Vancouver, Canada, Vol. 1, pp. 1 - 2, presented at SIGGRAPH 2018, Vancouver, Canada, 12 August 2018 - 16 August 2018,
    Conference Abstracts | 2018
    Forgam H; Esser L; Quinn JF; Mansfeld F; Slapetova I; Whan R; Ariotti N; Davis TP; Kavallaris M; McCarroll J, 2018, 'PO-354 Star-shaped gene silencing nanoparticles– an advanced approach to treating medulloblastoma', in ESMO Open, Elsevier BV, Vol. 3, pp. A367 - A368,
    Conference Abstracts | 2018
    Voli F; Lerra L; Kimpton K; Saletta F; Cirillo G; Kavallaris M; Vittorio O, 2018, 'Harnessing copper in cancer to enhance anti-tumor immune response', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWITZERLAND, Geneva, Vol. 29, pp. 35 - 35, presented at ESMO Immuno-Oncology Congress, SWITZERLAND, Geneva, 13 December 2018 - 16 December 2018,
    Conference Papers | 2017
    Ercole F; Mansfeld F; Kavallaris M; Whittaker M; Halls M; Davis T; Quinn J, 2017, 'Triggering cellular signalling processes with novel macromolecular hydrogen sulfide donors', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at 253rd National Meeting of the American-Chemical-Society (ACS) on Advanced Materials, Technologies, Systems, and Processes, CA, San Francisco, 02 April 2017 - 06 April 2017,
    Conference Papers | 2017
    Parker AL; Teo WS; McCarroll JA; Kavallaris M, 2017, 'Structural domains of ss III-Tubulin regulate multiple stress responses and influence cell growth and survival in glucose-deprived non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 01 April 2017 - 05 April 2017,
    Conference Papers | 2017
    Teo WS; Dwarte T; Failes TW; Arndt GM; McCarroll JA; Kavallaris M, 2017, 'High throughput kinase inhibitor screen reveals novel inhibitor combinations acting in synergy with TUBB3/beta III-tubulin suppression in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 01 April 2017 - 05 April 2017,
    Conference Abstracts | 2017
    Yee EMH; Brandl MB; Pasquier E; Cirillo G; Kimpton K; Kavallaris M; Kumar N; Vittorio O, 2017, 'Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells', in Scientific Reports, Springer Nature, England, Vol. 7, pp. 7638, England,
    Patents | 2016
    Kavallaris M; Gan P, 2016, Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents, China, Patent No.
    Conference Abstracts | 2016
    Parmar A; Vittorio O; Charil A; Kavallaris M; Pascali G, 2016, 'Imaging neuroblastoma xenograft using [Cu-64]CuCl2 for evaluation of novel treatment based on Dextran/Catechin conjugate', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, SPAIN, Barcelona, Vol. 43, pp. S480 - S480, presented at Annual Congress of the European-Association-of-Nuclear-Medicine, SPAIN, Barcelona, 15 October 2016 - 19 October 2016,
    Conference Papers | 2016
    Vittorio O; Brandl M; Cirillo G; Kimpton K; Hinde E; Duong HTT; Boyer C; Flemming C; Yee EMH; Kumar N; Parmar A; Pascali G; Charil A; Haber M; Norris M; Kavallaris M, 2016, 'Dextran-Catechin conjugate: An anticancer nano-modified natural compound targeting copper metabolism in neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016,
    Conference Abstracts | 2015
    Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP; Kavallaris M; Mccarroll J, 2015, 'Erratum: Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers (Molecular Pharmaceutics (2013) 10: 6 (2435−2444) DOI: 10.1021/mp400049e)', in Molecular Pharmaceutics, Vol. 12, pp. 1004,
    Conference Papers | 2015
    Kao FCL; Failes T; Arndt GM; Norris M; Kavallaris M, 2015, 'Discovery of a small molecule TUBB3/beta III-tubulin modulator in lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015,
    Conference Abstracts | 2015
    Sharbeen G; Liu J; McCarroll J; Limbri L; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414,
    Conference Abstracts | 2015
    Sharbeen G; McCarroll J; Liu J; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415,
    Conference Papers | 2014
    Fife CM; Byrne FL; Sagnella SM; Davis TP; McCarroll JA; Kavallaris M, 2014, 'Stathmin regulates cell migration, invasion and transendothelial migration via RhoA activation in neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,
    Conference Abstracts | 2014
    Kavallaris M, 2014, 'MICROTUBULE TARGETS IN CANCER: POTENTIAL OF NANOTECHNOLOGY-BASED THERAPEUTICS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 19 - 19,
    Conference Papers | 2014
    McCarroll JA; Gan PP; Erlich RB; Liu M; Dwarte T; Akerfeldt MC; Chang M; Shum MS; Byrne F; Kavallaris M, 2014, 'beta III-tubulin is required for the tumorigenic phenotype and resistance to anoikis via the PTEN/AKT signaling axis in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,
    Conference Papers | 2014
    Nakano M; Shirai R; Ito J; Kavallaris M; Packer N, 2014, 'Acquired drug resistance by decrease of sialylated glycans on acute lymphoblastic leukemia cell-membrane glycoproteins', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, HI, Honolulu, pp. 1217 - 1217, presented at Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), HI, Honolulu, 16 November 2014 - 19 November 2014,
    Conference Papers | 2014
    Parker A; McCarroll JA; Kavallaris M, 2014, 'beta III-Tubulin and cell survival: Novel role in endoplasmic reticulum stress and autophagy in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014,
    Conference Papers | 2014
    Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416,
    Conference Abstracts | 2014
    Yi H; Wang J; Kavallaris M; Wang JY, 2014, 'The identification of novel targets in beta-catenin-driven acute myeloid leukemic stem cells', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vol. 50, pp. S50 - S50,
    Conference Abstracts | 2013
    Kavallaris M; Kimpton K; Brandl M; Gobel A; Erlich R; Dwarte T; Mccarthy N; Sagnella S; Graham M; French P; Mccarroll J, 2013, 'SILENCING THE TUBB3 GENE IN VIVO SENSITISES NON-SMALL CELL LUNG CANCER TO CISPLATIN', in JOURNAL OF THORACIC ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 8, pp. S773 - S773,
    Conference Papers | 2013
    Liu PY; Tee A; Marshall G; Polly P; Wong M; Ling D; Kavallaris M; Perini G; Dinger ME; Liu T, 2013, 'Linc367, a novel long intergenic noncoding RNA, up-regulates N-Myc gene expression and neuroblastoma cell proliferation', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S356 - S356, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013,
    Conference Abstracts | 2013
    Mitic G; Tsoli M; Ziegler DS; Kavallaris M, 2013, 'beta III-tubulin in glioblastoma: An emerging multifactorial survival factor role in chemotherapy response and tumor formation.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013,
    Conference Papers | 2013
    Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381,
    Conference Papers | 2013
    Sharbeen G; Liu J; Mccarroll J; Youkhana J; Teo J; Mccarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12,
    Conference Papers | 2013
    Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385,
    Conference Papers | 2013
    Yi H; Wang J; Kavallaris M; Wang JY, 2013, 'Lgr4-Mediated Potentiation Of Wnt/beta-Catenin Signaling Promotes MLL Leukemogenesis Via An Rspo3/Wnt3a-Gnaq Pathway In Leukemic Stem Cells', in BLOOD, AMER SOC HEMATOLOGY, LA, New Orleans, presented at 55th Annual Meeting of the American-Society-of-Hematology, LA, New Orleans, 07 December 2013 - 10 December 2013,
    Conference Abstracts | 2012
    Byrne FL; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M, 2012, 'Stathmin suppression influences ROCK signaling and reduces cell invasion and metastasis in neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72,
    Conference Papers | 2012
    Hien D; Hughes F; Sagnella S; Kavallaris M; Hook J; Davis TP; Boyer C, 2012, 'Biodegradable and acid labile dextran-based nanoparticles for doxorubicin delivery', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, PA, Philadelphia, presented at 244th National Fall Meeting of the American-Chemical-Society (ACS), PA, Philadelphia, 19 August 2012 - 23 August 2012,
    Conference Abstracts | 2012
    Maritz M; Cowley MJ; Kaplan W; Kavallaris M; MacKenzie KL, 2012, 'Repression of Essential Telomerase Components Mediates Anti-proliferative Effects in Isogenic Immortal and Tumorigenic Cells, but not Normal Cells', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, Barcelona, Vol. 48, pp. S79 - S80, presented at 22nd Biennial Congress of the European-Association-for-Cancer-Research, SPAIN, Barcelona, 07 July 2012 - 10 July 2012,
    Conference Abstracts | 2012
    Mitic G; Tsoli M; Ziegler DS; Kavallaris M, 2012, 'beta III-TUBULIN AND GLIOBLASTOMA: ROLE IN DRUG RESISTANCE AND TUMOURIGENESIS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 303 - 304,
    Conference Abstracts | 2011
    Ciccolini J; Pasquier E; Fanciullino R; Serdjebi C; Mas C; Giacometti S; Kavallaris M; Andre N, 2011, 'Drug repositioning: Propanolol potentiates the anticancer efficacy of chemotherapeutic agents through modulation of angiogenesis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71,
    Conference Abstracts | 2011
    Failes T; Mitic G; Kavallaris M, 2011, 'Identifying the mechanisms of action and resistance to the novel multi-kinase inhibitor ENMD-2076 in leukemia', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 71,
    Conference Papers | 2011
    Kavallaris M, 2011, 'TARGETING DRUG RESISTANCE IN LUNG CANCER', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 415 - 416, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011,
    Conference Papers | 2010
    Byrne FL; McCarroll J; Kavallaris M, 2010, 'Abstract 5141: Stathmin mediates neuroblastoma migration and invasion via regulation of the actin network', in Cancer Research, American Association for Cancer Research (AACR), pp. 5141 - 5141, presented at Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC,
    Conference Abstracts | 2010
    Liu J; McCarroll J; Apte MV; Youkhana J; Kavallaris M; Phillips PA, 2010, 'Beta III- and Beta IVB-Tubulin Mediate Sensitivity to Chemotherapeutic Drugs in Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, pp. 1330 - 1330,
    Conference Abstracts | 2010
    Liu J; McCarroll J; Apte MV; Youkhana J; Kavallaris M; Phillips PA, 2010, 'Beta III- and beta IVb-tubulin mediate sensitivity to chemotherapeutic drugs in pancreatic cancer cells', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A76 - A76,
    Conference Papers | 2010
    McCarroll JA; Gan PP; Liu M; Dwarte T; Chang M; Byrne F; Kavallaris M, 2010, 'beta III-Tubulin regulates expression of proteins involved in tumorigenesis and metastasis in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH,
    Conference Papers | 2010
    McCarroll JA; Gan PP; Liu M; Dwarte T; Chang M; Byrne F; Kavallaris M, 2010, 'beta III-Tubulin regulates expression of proteins involved in tumorigenesis and metastasis in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH,
    Conference Papers | 2010
    Pasquier E; Sinnappan S; Munoz M; Kavallaris M, 2010, 'Abstract 4418: ENMD-1198, a new microtubule-targeting agent with potent anti-vascular properties', in Cancer Research, American Association for Cancer Research (AACR), pp. 4418 - 4418,
    Conference Papers | 2010
    Pasquier E; Sinnappan S; Verdier-Pinard P; Braguer D; Kavallaris M, 2010, 'Abstract LB-368: III-tubulin knockdown in endothelial cells increases the antivascular activity of chemotherapeutic drugs', in Cancer Research, American Association for Cancer Research (AACR), presented at Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC,
    Conference Papers | 2010
    Wen VW; Kan F; Pasquier E; Chang M; Kavallaris M; Mackenzie KL, 2010, 'Molecular and functional alterations associated with repression of tumor suppressor p16INK4a during immortalization of human endothelial cells', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, presented at Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC,
    Conference Papers | 2009
    Failes TW; Mitic G; Abdel-Halim H; Liu M; Bray MR; Hibbs DE; Kavallaris M, 2009, 'Abstract A156: Mechanisms of resistance to Aurora kinase B inhibitors in leukemia: Development and characterization of in vitro models', in Molecular Cancer Therapeutics, American Association for Cancer Research (AACR), pp. A156 - A156,
    Conference Papers | 2009
    Failes TW; Mitic G; Abdel-Halim H; Liu M; Bray MR; Hibbs DE; Kavallaris M, 2009, 'Mechanisms of resistance to Aurora kinase B inhibitors in leukemia: Development and characterization of in vitro models', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH,
    Conference Abstracts | 2009
    Gan PP; Kamath K; Jordan MA; Kavallaris M, 2009, 'Differential effects of \#946;III-tubulin on drug-induced microtubule dynamics and mitotic arrest', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 69,
    Conference Abstracts | 2009
    McCarroll J; Gan PP; Kavallaris M, 2009, 'Novel role of \#946;III-tubulin in tumorigenesis and drug sensitivity in non-small cell lung cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 69,
    Conference Papers | 2008
    Bell JL; Cheung BB; D'Andreti C; Koach J; Raif A; Thomas WD; Norris M; Haber M; Kavallaris M; Marshall GM, 2008, 'The role of the estrogen-responsive B box protein (EBBP) in cancer cell cycle progression', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, FRANCE, Lyon, pp. 95 - 95, presented at 20th Meeting of the European-Association-for-Cancer-Research, FRANCE, Lyon, 05 July 2008 - 08 July 2008,
    Conference Papers | 2008
    Valade D; Boyer CA; Bulmus V; Kavallaris M; Davis TP; Mccaroll J, 2008, 'Development of siRNA-Polymer Conjugates and Polyplexes', in Development of siRNA-Polymer Conjugates and Polyplexes, 30th Australasian Polymer Symposium, Melbourne, Australia, presented at 30th Australasian Polymer Symposium, Melbourne, Australia, 30 November 2008 - 04 December 2008
    Conference Papers | 2007
    Liaw T; Burke P; Chen X; LaVallee T; Lock RB; Kavallaris M, 2007, 'ENMD-1198 in combination with vincristine shows synergistic activity in leukemia cells and prolonged mouse survival in human leukemia xenografts', in Broze G (ed.), Blood, American Society of Hematology, USA, pp. 859 - 859, presented at 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, Georgia USA, 08 December 2007 - 11 December 2007
    Conference Papers | 2007
    Liaw TTYE; Burke PPA; Chen X; LaVallee TTM; Lock R; Kavallaris M, 2007, 'ENMD-1198 in combination with vincristine shows synergistic activity in leukemia cells and prolonged mouse survival in human leukemia xenografts', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, pp. 263A - 263A, presented at 49th Annual Meeting of the American-Society-of-Hematology, GA, Atlanta, 08 December 2007 - 11 December 2007,
    Conference Abstracts | 2006
    Chang MHY; Engelander J; Verrills NM; Tait AS; Kavallaris M, 2006, 'Differential proteomic analysis of low-level anti-microtubule resistance in acute lymphoblastic leukaemia', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 4, pp. 57 - 57,
    Conference Papers | 2006
    Cheung BB; Bell J; Raif A; Yan J; Roediger B; Smith S; Lee M; Thomas WD; Kavallaris M; Norris M; Haber M; Liu H-L; Zajchowski D; Marshall GM, 2006, 'Characterization of a novel regulator of the retinoid signal: The estrogen-responsive B box protein.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH,
    Conference Papers | 2004
    Schevzov G; Vrhovski B; Bryce NS; Elmir S; Qiu M; Yang N; Verrills NM; Kavallaris M; Puttur F; Hardeman E; Gunning P, 2004, 'Tropomyosin antibodies identify functionally distinct populations of actin filaments', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, DC, Washington, pp. 143A - 143A, presented at Annual Meeting of the American-Society-for-Cell-Biology, DC, Washington, 04 December 2004 - 08 December 2004,
    Conference Papers | 2002
    Verrills N; Flemming C; Liu M; Ivery M; Norris MD; Haber M; Kavallaris M, 2002, 'Acquired beta-tubulin mutations affecting microtubule stability and drug binding', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, CALIFORNIA, SAN FRANCISCO, pp. 463A - 463A, presented at 42nd Annual Meeting of the American-Society-for-Cell-Biology, CALIFORNIA, SAN FRANCISCO, 14 December 2002 - 18 December 2002,
    Conference Abstracts | 1985
    STEWART BW; KAVALLARIS M; SMITH GJ; HABER M, 1985, 'MONITORING REPAIR AND REPLICATIVE-INDUCED STRUCTURAL-CHANGE IN CULTURES OF PROLIFERATING MAMMALIAN-CELLS', in MEDICAL AND PEDIATRIC ONCOLOGY, WILEY-LISS, Vol. 13, pp. 135 - 135,
    Preprints |
    Utama RH; Atapattu L; O' Mahony AP; Fife CM; Baek J; Allard T; O' Mahony KJ; Ribeiro J; Gaus K; Kavallaris M; Gooding J, A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids, ,

Outstanding track record of attracting competitive peer-reviewed research funding throughout career having secured more than $70 million in support either as lead or co-investigator. This includes lead Chief Investigator (CI) on an NHMRC Program Grant ($7M; 2016-21), NHMRC Investigator Grant ($2.45M; 2023-27), NHMRC Synergy Grant (2023-2027), co-CI ARC Centre of Excellence (2014-21), Cancer Australia (2020-22), NSW Cancer Council (2023-25), Tour de Cure (2022-24), and Neuroblastoma Australia (2023-24).

Professor Kavallaris has held numerous prestigious fellowships that include: IARC Cancer Research Training Award, NHMRC RD Wright Fellowship, NHMRC Senior Research Fellowship, NHMRC Principal Research Fellowship, and NHMRC Investigator.

Fellowships

2023-2027 NHMRC Investigator (Level 3)

2017-2021 NHMRC Principal Research Fellowship

2014-2018 NHMRC Established Career Fellowship

2009 – 2013 NHMRC Senior Research Fellowship

2004 – 2008 NHMRC RD Wright Career Development Fellowship

1996 International Agency for Research on Cancer, Cancer Research Training Fellowship*. World Health Organisation. Host: Prof. Susan B Horwitz, Department Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. *Highly competitive fellowship with only 13 awarded worldwide in 1995.

Prizes/Awards

2022 Presidential Medal for Outstanding Contributions, Republic of Cyprus

2021 ANSTO Eureka Prize for Innovative Use of Technology

2020 NSW Premier's Woman of the Year

2019 Lemberg Medal, ASBMB

2019 UTS Chancellor’s Excellence Award

2019 UTS Alumni Excellence Award for Science

2019 Member of the Order of Australia (AM)

2017 Premier's Science and Engineering Prize for Leadership in Innovation in NSW

2015 AFR/Westpac 100 Women of Influence

2015 “Knowledge Nation 100” (Australia’s top 100 visionaries, intellects, founders and game changers who help shape the country’s future prosperity).

2015 The Australian Financial Review & Westpac “100 Women of Influence” Award

2013 NSInnovations People’s Choice Award and Division Finalist for the “”

2011 OEEGA International Women’s Day – Award for Excellence in the field of Scientific Research

2007 Australian Museum Eureka Prize for Voiceless Research Which Replaces the Use of Animals or Animal Products – “Unravelling the Enigma of Drug Resistance in Cancer”

2007 Visiting Professorship Awarded from the University of Marseille, France (all expenses paid)

2005 Achievement Award International Women’s Day – in recognition of “extraordinary contributions to research”, Cyprus Community of NSW

2004 Young Tall Poppy Award – recognises “achievements of outstanding young researchers in the sciences and biomedical sciences”, Australian Institute of Policy and Science

2002 Institute Award - Children’s Cancer Institute Australia for Outstanding Service in Pursuit of the Institute’s Vision

1998 Leo & Jenny Leukaemia and Cancer Foundation Your Research of the Year. Finalist and Merit Certificate Awardee.

1998 Bristol Myers Squibb Oncology Young Investigator Award – American Association for Cancer Research Meeting, New Orleans, March, 1998. Highly competitive award.

1997 B G Levanthal Scholar Award – Women in Cancer Research. American Association for Cancer Research Meeting, San Diego, CA, April 1997. Highly competitive award.

1996 Bristol Myers Squibb Oncology Travel Award – American Association for Cancer Research Meeting, Washington DC, April 1996. Highly competitive.

1994 NSW State Cancer Council Travel Grant.

1990 Tow Research Prize – Coast Medical Association Meeting, Prince Henry Hospital, NSW, Australia